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ABSTRACT
Objective: To analyze the association between the surgical characteristics of breast 
implants, time elapsed since surgery, access route, implant placement and implanted volume 
and variables related to breastfeeding, type, first ‘milk let-down’, breast engorgement, 
pain, lesion, milk production and use of galactagogues. Method: A prospective cohort 
carried out during the hospital stay (12 to 72 hours after delivery), home care (5th to 7th 
day after delivery) and telephone contact (between the 30th and 32nd day postpartum) 
of 115 postpartum women with breast implants between 2015 and 2017. Results: The 
first evaluation identified more frequent use of oral galactagogues (p=0.029) by puerperal 
women with prepectoral implants, and of oxytocin spray by those with implants up to 
270 ml (p=0.040). The second evaluation showed a higher pain score among those with 
prepectoral implants (p=0.046). Around the 30th day postpartum, the presence of nipple 
lesion (p=0.021), pain (p=0.025) and a higher pain score (p=0.039) was more frequent 
among those with mammoplasty performed less than 10 years ago. Conclusion: The 
presence of pain and a higher pain score, the occurrence of lesion and the use of oral 
and nasal galactagogues were associated with implant placement, implant size and time 
elapsed since surgery. 
DESCRIPTORS
Breast Feeding; Mammaplasty; Breast Implantation; Obstetric Nursing. 
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INTRODUCTION
Exclusive breastfeeding (EBF) for 6 months, continued 
breastfeeding and the introduction of appropriate comple-
mentary food have numerous benefits for the health and 
survival of children, in addition to playing an important role 
in women’s and in society health(1). 
Despite all the available evidence on the importance 
of this practice, Brazil is still far from complying with 
the recommendation of exclusive breastfeeding up to 6 
months of life, as recommended by the World Health 
Organization (WHO)(1). Causes associated with early 
breastfeeding termination have been frequently described 
in scientific literature. Breast surgeries have been listed 
as one of the causes of factors associated with milk pro-
duction incapacity, as the surgery can alter the integrity 
and functioning condition of the breast depending on 
the surgical technique used, making it difficult or even 
preventing breastfeeding(2-3).
With advancing technology involved in manufactur-
ing breast implants as well as in the surgical techniques, 
this procedure has been growing in Brazil and around 
the world(2). The latest study by the International Society of 
Aesthetic Plastic Surgery (ISAPS) carried out in 2016 shows 
that this cosmetic surgery is the most frequent in Brazil, 
occupying second place in the world ranking only behind 
the United States(4).
The search for the ideal body generally occurs during 
the reproductive period, between 19 and 34 years of age, 
when most women do not care about their future ability to 
breastfeed, often because they still do not plan or are not 
experiencing motherhood(5).
In this regard, it is essential that women, especially those 
within the reproductive age who wish to become pregnant 
and breastfeed, are fully informed of the benefits of breast-
feeding, as well as on the possible complications resulting 
from mammoplasty surgery for future lactation(6).
On the other hand, health professionals must under-
stand the nature of the surgery and the probable results 
related to breastfeeding. The woman should be closely 
monitored by a trained professional soon after delivery in 
order to evaluate the signs of adequate milk production 
and infant growth, seeking the provision of the necessary 
care in each case(7).
Studies published over the last decades up to the present 
have been analyzed in order to identify the repercussions 
of breast implants in breastfeeding based on a scientific 
approach. In addition to the scarcity, it is observed that the 
majority of articles refer to old studies, and few of them 
correlate surgical characteristics with the aspects associated 
with breastfeeding. In addition, they also present low levels 
of evidence, no precise definitions regarding the outcome 
(EBF), and are retrospective studies with small populations, 
thus hindering data generalization and comparability.
Based on the gaps identified and the importance of guid-
ing women and professional qualification, the present study 
sought to analyze the association between the surgical char-
acteristics of breast augmentation such as the time elapsed 
since surgery, access route, implant placement and implant 
volume, and the variables related to breastfeeding such as 
type, occurrence of ‘milk let-down’, breast engorgement, pain 
at breastfeeding, nipple lesion, milk production and use of 
galactagogues. 
METHOD
This study is a part from a larger Research Project enti-
tled ‘The Impact of Reduction Mammoplasty and Increasing 
Breastfeeding Performance’ (O Impacto da Mamoplastia 
Redutora e de Aumento na Performance da Amamentação), per-
formed from a prospective cohort study in a private hospital 
located in the city of São Paulo with 240 women; 125 in 
the group without surgery, and 115 in the group with breast 
augmentation. For the proposed objective, only primiparous 
women with breast implants between 12 and 72 hours post-
partum who had not experienced ‘milk let-down’, who were 
breastfeeding, and who were aware of the characteristics of 
the surgical procedure analyzed were selected.
The exclusion criteria were women with any previous 
pathology and/or those associated with pregnancy; whose 
current gestation was characterized as multiple; with nipple 
malformation; with a diagnosis of tuberous breasts; who 
had undergone breast implant replacement or reopera-
tion or had undergone any other breast surgery other than 
implant mammoplasty; who underwent surgery on a single 
breast; who presented complications related to breast aug-
mentation (infectious processes, bruises, seromas, implant 
rupture, capsular contracture, among others); women whose 
newborns had been admitted to the Intensive Care Unit 
and/or were premature and/or weigh less than 2,500 grams, 
those who had had any pathology at birth and/or orofa-
cial malformation; women who declared themselves to be 
non-literate and/or those with cognitive deficits, regard-
less of the schooling level, unable to read and understand 
the clear and Informed Consent Term; those with hearing 
and/or visual impairments; or those disoriented as to time, 
space or people.
In order to respond to the research objective, the primary 
outcome variable established was the type of breastfeeding 
practiced, while the variables related to breastfeeding and the 
surgical characteristics of breast augmentation were estab-
lished as secondary outcomes.
Three instruments were specifically developed for this 
study, and all three were previously tested based on a 
pilot project. The first instrument was applied in the first 
evaluation during hospital care which occurred between 
12 and 72 hours after delivery and included: recording 
of socio-demographic data (maternal age, marital sta-
tus, schooling and occupation); data regarding birth and 
delivery (type of delivery, gestational age, birth weight 
of the child and gender of the child); breastfeeding (type 
of breastfeeding, period of ‘milk let-down’, presence of 
breast engorgement, pain while breastfeeding and nip-
ple lesion, milk production and use of galactagogues); 
physical breast examination and referring to the time 
elapsed since surgery (categorized as up to 10 years and 
more than 10 years); access route for the implantation, 
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obtained through an evaluation of the scar and catego-
rized as periareolar, inframammary and others (axillary 
and umbilical); implant placement (categorized as prepec-
toral or retro-pectoral); and volume implanted in each 
breast (categorized as less than or equal to 270 ml and 
greater than 270 ml).
The second instrument was used in the second evalu-
ation during home consultation, performed between the 
5th and the 7th day after delivery. The data included were: 
physical breast examination, data related to breastfeeding, an 
evaluation of milk production and observation of a breast-
feeding session.
For evaluating the milk production, an electric pump 
was simultaneously used for 10 minutes(8), with a suction 
pressure vacuum of 190.7±8.8 millimeters of mercury 
(mmHg)(9) and a rate of 50 to 60 movements per min-
ute(2), calibrated using a specific instrument and trained 
professional. No breast manipulations or massages were 
carried out prior to the extraction, and an areolar flexibility 
test was performed. The volume of pumped milk was eval-
uated in milliliters based on the content aspiration using a 
disposable 20 ml syringe. 
The third instrument was applied in the 3rd evaluation 
through telephone contact between the 30th and 32nd day 
postpartum, and it consisted of a form that included data 
related to breastfeeding and information on breast condi-
tions (lesions and pain).
In the three instruments, the pain score during breast-
feeding was evaluated by the Verbal Number Scale graded 
from 0 to 10, in which 0 means absence of pain, and 10 the 
worst pain ever felt(10). The pain intensity was then classified 
as an absolute number. 
The data collection began in January 2015, after 
approval by the Research Ethics Committee of the 
Universidade Federal de São Paulo – UNIFESP, of the 
Ethics Committee of the Albert Einstein Israelita Hospital 
– HIAE, under number 855.285/2014, and upon the accep-
tance and signature of the clear and Informed Consent 
Form (ICF) by the study subjects. The collection was final-
ized in April 2017. 
The data were collected in three stages by the 
researcher and by a team of properly trained and qualified 
nurses to perform the present collection who had expe-
rience with the basic management of breastfeeding. The 
first stage occurred in the hospital environment, between 
12 and 72 hours after delivery. A survey of hospitalized 
postpartum women was performed daily, and those that 
met the inclusion and exclusion criteria were selected 
and included in the study according to the information 
described in their records. These women were subse-
quently interviewed in their respective rooms, with the 
purpose of checking the data contained in the medical 
records, as well as to confirm the presence or absence of 
breast implants. Based on this information, the order for 
the women for beginning the data collection was done 
at random by a draw. After this process, the puerperal 
women were again approached for presenting the study 
and were invited to participate. Upon acceptance, the 
women were included after signing the ICF.
In the second stage, an evaluation of the women and 
newborns was carried out between the 5th and the 7th day 
postpartum through a home visit at a previously scheduled 
time and close to feeding time. In the third stage, the data 
was collected through telephone contact between the 30th 
and 32nd day after birth.
The analyzed periods were established for evaluation 
of the variables that directly interfere in the breastfeeding 
process as the physiological changes in lactation occur, 
contemplating its initial phase (12 to 72 hours after 
delivery), the ‘milk let-down’ period (5th to 7th day after 
delivery) and the establishment of this practice (30th to 
32nd day postpartum). 
There were some losses during the follow-up in the eval-
uation between the 5th and the 7th day after delivery; 19 
puerperal women refused the home visit, and 13 presented 
nipple lesion and/or pain during milk extraction with the use 
of the electric pump and were excluded, totaling 83 women, 
while 88 women responded to the telephone contact at 30 
days postpartum. 
The collected data were stored in an Excel spread-
sheet, and the considered significance level was 5%. 
Mean, standard deviation, median, minimum and maxi-
mum were used for the quantitative data, and they were 
analyzed using the Student’s t and Mann-Whitney tests 
when associated with dichotomous categorical data. 
The association of categorical data was analyzed using 
Fisher’s Exact Test. 
The guidelines and norms of Resolution No. 466/2012 of 
the National Health Council were considered in developing 
the present study.
RESULTS
When analyzing the sociodemographic profile of women 
and the labor and delivery characteristics, we observed that 
the mean age of participants was 33 years, 99.2% of them 
had a partner, 99.1% reached the Higher Education level 
(incomplete/complete) and 83.6% were employed in a high 
education profession at the data collection time. Regarding 
the characteristics of labor and delivery, 73.6% had cesar-
ean delivery, the mean gestational age was 39 weeks, birth 
weight was 3,286.2 ± 339.1 g, and male infants were more 
frequent (53.9%). 
Regarding the surgical characteristics, 74.8% of the 115 
women studied had undergone the surgery up to 10 years 
ago, 88.7% of them had an inframammary incision, and the 
mean implanted volume was 267 ml (267±48.4), in which 
the maximum was of 400 ml and the minimum was 100 ml, 
while 52.1% reported that the implant was inserted in the 
prepectoral space. 
The implanted volume variable was dichotomized for 
analysis into less than 270 ml and higher or equal to 270 
ml, according to the average found.
Table 1 shows the type of breastfeeding practiced 
according to the surgical characteristics for the three 
moments evaluated.
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Data from Table 2 shows the results corresponding to 
the periods of ‘milk let-down’, breast engorgement and milk 
production, which were evaluated between the 5th and 7th day 
postpartum, which showed no relationship with the analyzed 
surgical characteristics. 
Table 1 – Information related to the type of breastfeeding practiced at the three evaluated moments, according to surgical characte-
ristics – São Paulo, SP, Brazil, 2015-2017.
GROUPS n
12 to 72 hours after delivery
Type of breastfeeding (%)
n
5th to 7th day after delivery
Type of breastfeeding (%)
n
30th to 32nd day after delivery 
Type of breastfeeding (%)
Exclusive Not exclusive P-value Exclusive
Not 
exclusive P-value Exclusive
Not 
exclusive P-value
Time elapsed since surgery
≤10 years 86 93.0 7.0 0.269 62 77.4 22.6 0.999 66 59.0 41.0 0.999
>10 years 29 86.2 13.8 21 81.0 19.0 22 59.1 40.9
Access route
Periareolar 13 100.0 0.0 0.591 8 100.0 0.0 0.193 10 60.0 40.0 0.999
Inframammary 90 92.2 7.8 65 77.0 23.0 68 60.3 39.7
Implant placement
Prepectoral 60 96.7 3.3 0.076 43 81.4 18.6 0.418 47 55.3 44.7 0.658
Retro-pectoral 50 86.0 14.0 35 71.4 28.6 36 61.1 38.9
Implanted volume
≤270mL 48 93.7 6.3 0.717 37 83.8 16.2 0.254 39 61.5 38.5 0.482
>270mL 52 90.4 9.6 33 69.7 30.3 35 51.4 48.6
Fisher’s Exact Test.
Table 2 – Information related to the period of occurrence of the ‘milk let-down’, breast engorgement and milk production according 
to surgical characteristics – São Paulo, SP, Brazil, 2015-2017.
Population 
analyzed n
Period of occurrence of the 
‘milk let-down’ (%)
Breast 
engorgement (%)
Milk production
(Mean ± SD*)
Between 
the 2nd/3rd 
dpp
After the 
4th dpp P-value Yes No P-value
Right 
breast P-value
Left 
breast P-value
Time elapsed since surgery
≤10 years 62 54.9 45.1 0.209 27.4 72.6 0.276 27.4±24.0 0.375 28.8±23.8 0.741
>10 years 21 71.4 28.6 42.9 57.1 20.1±12.6 28.1±19.4
Access route
Periareolar 8 25.0 75.0 0.065 37.5 62.5 0.682 32.6±41.1 0.979 31.7±34.6 0.999
Inframammary 65 61.5 38.5 27.7 72.3 24.3±19.8 27.4±22.5
Implant placement
Prepectoral 43 65.2 34.8 0.253 32.6 67.4 0.999 26±21 0.429 29.9±23.7 0.487
Retro-pectoral 35 51.4 48.6 31.4 68.6 24.2±24.2 26.4±22.9
Implanted volume
≤270mL 37 67.6 32.4 0.224 35.1 64.9 0.434 28.2±25.7 0.194 31.5±26.5 0.307
>270mL 33 51.5 48.5 24.3 75.7 22.1±19.1 23.3±17.4
Fisher’s Exact Test. *Mann-Whitney. SD=Standard deviation. dpp= days postpartum.
Regarding the use of oxytocin spray, the results showed 
that this medication was more frequently used between the 
5th and 7th day postpartum by the group of women with 
smaller implants when compared to those with larger 
implants, and this difference was significant (p=0.040). The 
use of oral galactagogues in the first evaluation was more fre-
quent among women with prepectoral implants (p=0.029), 
as shown in Table 3.
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Around 30 days postpartum, the presence of pain 
(p=0.025) and nipple lesion (p=0.021) was more observed 
in women with mammoplasty performed less than 10 years 
ago, as shown in Table 4. 
Table 3 – Information regarding the use of oxytocin spray and oral galactagogues according to surgical characteristics – São Paulo, SP, 
Brazil, 2015-2017.
Population analyzed n
12 to 72 hours after delivery
n
5th to 7th day after delivery
n
30th to 32nd day after delivery
Yes No P-value Yes No P-value Yes No P-value
USE OF OXYTOCIN SPRAY (%)
Time elapsed since surgery
≤10 years 86 28 72 0.811 62 30.7 69.3 0.166 66 3 97 0.097
>10 years 29 24.1 75.9 21 14.3 85.7 22 13.7 86.3
Access route
Periareolar 13 38.5 61.5 0.296 8 37.5 62.5 0.378 10 10 90 0.429
Inframammary 90 22.2 77.8 65 21.5 78.5 68 4.4 95.6
Implant placement
Prepectoral 60 26.7 73.3 0.999 43 20.1 79 0.311 47 2.1 97.9 0.576
Retro-pectoral 50 28 72 35 31.4 68.6 36 5.6 94.4
Implanted volume
≤270mL 48 25 75 0.656 37 19 81 0.04 39 7.7 92.3 0.617
>270mL 52 30.7 69.3 33 42.4 57.6 35 2.9 97.1
USE OF ORAL GALACTAGOGUES (%)
Time elapsed since surgery
≤10 years 86 10.5 89.5 0.448 62 19.3 80.7 0.168 66 40.9 59.1 0.804
>10 years 29 3.4 96.6 21 4.8 95.2 22 36.4 63.6
Access route
Periareolar 13 0 100 0.591 8 0 100 0.586 10 20 80 0.307
Inframammary 90 8.9 91.1 65 12.3 87.7 68 39.7 60.3
Implant placement
Prepectoral 60 8.3 91.7 0.999 43 7 93 0.029 47 34 66 0.37
Retro-pectoral 50 10 90 35 25.7 74.3 36 44.4 55.6
Implanted volume
≤270mL 48 10.4 89.6 0.734 37 16.2 83.8 0.76 39 41 59 0.999
>270mL 52 7.7 92.3 33 21.2 78.8 35 42.9 57.1
Fisher’s Exact Test.
Table 4 – Information related to the presence of breast pain and nipple lesion according to surgical characteristics – São Paulo, SP, 
Brazil, 2015-2017.
Population analyzed n
12 to 72 hours after delivery
n
5th to 7th day after delivery
n
30th to 32nd day after delivery
Yes No P-value Yes No P-value Yes No P-value
USE OF OXYTOCIN SPRAY (%)
Time elapsed since surgery
≤10 years 86 39.5 60.5 0.508 62 66.1 33.9 0.999 66 19.7 80.3 0.025
>10 years 29 31.0 69.0 21 66.7 33.3 22 45.4 54.6
Access route
Periareolar 13 53.9 46.1 0.232 8 75.0 25.0 0.999 10 30.0 70.0 0.689
Inframammary 90 35.6 64.4 65 67.7 32.3 68 22.1 77.9
Implant placement
Prepectoral 60 35.0 65.0 0.843 43 72.1 27.9 0.232 47 29.8 70.2 0.319
Retro-pectoral 50 38.0 62.0 35 57.1 42.9 36 19.4 80.6
Implanted volume
≤270mL 48 33.3 66.7 0.308 37 73.0 27.0 0.315 39 23.1 76.9 0.445
>270mL 52 44.3 55.7 33 60.6 39.4 35 31.4 68.6
NIPPLE LESION (%)
Time elapsed since surgery
≤10 years 86 46.5 53.5 0.286 62 83.9 16.1 0.514 66 18.1 81.9 0.021
>10 years 29 34.5 65.5 21 76.2 23.8 22 45.4 54.6
Access route
Periareolar 13 69.2 30.8 0.071 8 75.0 25.0 0.611 10 30.0 70.0 0.682
Inframammary 90 40.0 60.0 65 84.6 15.4 68 20.6 79.4
Implant placement
Prepectoral 60 41.7 58.3 0.848 43 83.7 16.3 0.567 47 27.6 72.4 0.445
Retro-pectoral 50 44.0 56.0 35 77.1 22.9 36 19.4 80.6
Implanted volume
≤270mL 48 43.7 56.3 0.554 37 83.8 16.2 0.760 39 20.5 79.5 0.302
>270mL 52 50.0 50.0 33 78.8 21.2 35 31.4 68.6
Fisher’s Exact Test.
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With regard to the pain score between the 5th and 7th 
day after delivery, a higher pain score was identified among 
women with prepectoral implants (p=0.046), while the 
highest score (p=0.039) around the 30th day was observed 
among postpartum women who underwent surgery less than 
10 years ago.
Table 5 – Information related to pain during breastfeeding on right and left breasts, according to surgical characteristics – São Paulo, 
SP, Brazil, 2015-2017.
Population
analyzed n
12 to 72 hours after delivery
Pain scores during breastfeeding
 (Mean ± SD*)
n
5th to 7th day after delivery
Pain scores during breastfeeding
(Mean ± SD*)
n
30th to 32nd day after delivery
Pain scores during breastfeeding 
(Mean ± SD*)
Right 
breast P-value Left P-Valor
Right 
breast P-value Left P-Valor
Right 
breast P-value Left P-value
Time elapsed since surgery
≤10 years 86 1.8±2.8 0.927 2.1±3.0 0.302 62 4.2±3.5 0.460 4.1±3.5 0.810 66 0.6±1.8 0.039 0.8±2.1 0.55
>10 years 29 1.9±3.1 1.6±3.0 21 4.8±3.8 4.3±3.7 22 1.1±1.8 1.5±2.1
Access route
Periareolar 13 2.3±3.2 0.629 3.0±3.3 0.143 8 6.2±4.1 0.131 6.1±4.0 0.120 10 1.5±2.7 0.140 1.3±3.2 0.992
Inframammary 90 1.8±2.9 1.8±3.0 65 4.4±3.5 4.0±3.4 68 0.4±1.3 1.0±2.0
Implant placement
Prepectoral 60 1.5±2.6 0.416 1.8±2.7 0.786 43 5.1±3.5 0.058 4.8±3.6 0.046 47 0.7±1.5 0.869 1.0±4.9 0.347
Retro-pectoral 50 2.1±3.2 2.0±3.2 35 3.6±3.4 3.3±3.2 36 0.8±2.2 0.8±2.4
Implanted volume
≤270mL 48 1.2±2.2 0.107 1.4±2.4 0.052 37 4.9±3.2 0.490 4.1±3.1 0.573 39 0.6±1.6 0.663 0.9±2.1 0.507
>270mL 52 2.4±3.3 2.6±3.3 33 4.7±3.9 4.4±3.9 35 1.0±2.2 2.2±2.4
*Mann-Whitney. SD=Standard deviation.
DISCUSSION
No significant differences were observed in the three 
evaluations between the analyzed groups when ana-
lyzing the EBF rate and its relationship with the time 
elapsed since surgery, access route, implant placement 
and implanted volume. In comparing the prevalence of 
EBF in the three evaluated moments, a decrease in this 
practice was observed in relation to the four surgical char-
acteristics evaluated, demonstrating that the higher the 
postpartum period, the greater the risk of weaning, which 
corroborates the rates found in the general population, as 
evidenced in the last Study of Breastfeeding Prevalence 
in the Brazilian Capitals and Federal District, published 
in 2009(11).
Regarding the time elapsed since surgery, only one recent 
retrospective study related this variable to EBF rates, and 
unlike the present study it identified that women with 
augmentation surgery performed up to two years prior to 
delivery had similar frequencies of EBF to the frequencies 
found in women who had performed the procedure a longer 
time prior(12). 
With regard to the access route, only two studies con-
ducted this description(13-14) according to the literature 
review; however, only one of them evaluated the correlation 
between the EBF rate and the type of incision(14). 
The first was conducted in 1993, and refers to a retro-
spective study of 26 women who underwent breast aug-
mentation and reported that only a few women stopped 
breastfeeding at 3 months, and the vast majority continued 
to breastfeed for 6 months or longer. The authors also iden-
tified that 11 of them presented inframammary incision, 
seven presented periareolar incision, and one axillary 
incision(13), although the descriptions of the incision type 
did not add up to the number of women studied (n=26), 
meaning that this variable was not characterized for seven 
women. Moreover, there is no information on the number 
of women with each type of incision and how long they 
exclusively breastfed for.
The second reference is a retrospective study conducted 
at the Universidad de Puerto Rico in 2010 with 105 women 
with breast implant surgery; 49 with periareolar incision 
and 56 with inframammary incision. The study identified 
that the success rate of exclusive breastfeeding decreased 
approximately by 25%, and the need to supplement with 
artificial milk increased by 19%, regardless of the type of 
incision(14). These results corroborate those found in the 
present study, since it was observed that women with 
inframammary incisions presented higher EBF rates at 
all analyzed moments even though it was not evidenced 
by the statistical test.
In this sense, women with periareolar incisions are five 
times more likely to have insufficient milk production due 
to damage to the ducts, glandular tissue or innervation 
of the breast, which results in partial or total loss of the 
sucking reflex, reduced milk production, and consequently 
early weaning(15). 
No studies that investigated implant placement and 
implant volume were found in the analyzed literature. 
Although the results showed no significant difference, 
women with prepectoral implants had a higher EBF 
rate up to 5 to 7 days after delivery; a fact that can 
be justified by the compression of the mammary gland, 
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which is especially stiffened during ‘milk let-down’ with 
the alveoli and ducts dilated which can facilitate milk 
ejection, thereby promoting the sensation of adequate 
milk production. However, after stage II of lactogenesis, 
the production regulation becomes autocrine and with 
regular emptying of the mammary gland, and there is 
reduced interalveolar pressures(16), which may disclose 
reduced lactation in women with prepectoral implants 
and consequently to a need for complementation with 
artificial milk/formula.
It is important to note that the duration of EBF may 
not only be associated with physiological factors related 
to breast implants. In general, women who choose to 
perform this procedure may have different expectations 
and beliefs from those who did not. They may have lower 
self-esteem and self-confidence, not feeling able to meet 
the child’s needs. On the other hand, they may be less 
perseverant when faced with obstacles and difficulties 
inherent in the breastfeeding process(17), which also favors 
early weaning. 
Regarding the occurrence of breast engorgement, it was 
observed that the percentage found in the analyzed groups 
is consistent with that described in the general literature, 
which shows an incidence that varies widely from 28.3% 
(18) to 89%(19). However, the studies do not report an asso-
ciation between breast engorgement and breast implants, 
they only relate that cases with periareolar incisions could 
lead to a reduction or incapacity of milk drainage due to 
the section of the ducts and the presence of the implant, 
especially the prepectoral ones, which compress the mam-
mary gland(20), thus worsening alveolar distention and even 
increasing obstruction, which was not evidenced in the 
present study.
The analyzed literature and the results of the present 
research regarding milk production are not consensual. 
An American study used the Lactina electric pump with 
simultaneous extraction to evaluate milk production of 
two puerperal women with breast implants with periare-
olar incision from the 4th day after delivery, demonstrat-
ing a significant reduction in milk production over time 
in both cases; however, they were women with premature 
births (one of them triplets) and with hospitalization 
of the newborns in the intensive care unit, which may 
have influenced the results encountered(5). Other stud-
ies used different ways of measuring production such 
as manual milking(21), weight gain(15,22) and the report 
of women(23-24), concluding that breast augmentation 
surgeries negatively interfere with milk production(15,22), 
especially those with periareolar incision(15,22). Only one 
study stated that the surgical procedure did not affect 
the ability to produce milk(24). In addition to differences 
regarding the population, the extraction type used and 
non-standardization of using the electric pump in rela-
tion to the extraction frequency, duration, rhythm and 
suction pressure may justify the disagreement of the 
presented data. 
No studies correlating surgical characteristics with the 
use of galactagogues were found in the studied literature. 
The results of the present study have highlighted a more 
frequent use of oxytocin spray by women with implanted 
volume of up to 270 ml, between the 5th and the 7th day after 
delivery. This data may be related to the greater compression 
on the gland exerted by larger implants, making it possible 
for women with smaller implants to notice early reduction 
of milk ejection and production, with consequent use of 
this input. 
Oral galactagogues were more common among puer-
peral women with prepectoral implants between the 5th and 
7th day after delivery. These results may occur due to the 
greater compression of the mammary gland in the pres-
ence of prepectoral implants, leading to a reduction in milk 
drainage and greater use of these medications in the period 
after ‘milk let-down’.
These results may also point to the indiscriminate 
and increasingly common use of galactagogues in daily 
practice, which are mostly prescribed without previ-
ous clinical evaluation and in an inadequate manner by 
trained professionals.
Regarding the presence of pain in breastfeeding and 
the occurrence of nipple lesion, no similar studies were 
found in the analyzed literature that allowed comparability 
of the results identified; however, it is known that pain in 
women with breast implants can not only result from the 
breastfeeding process, but also from the trauma of the sur-
gical procedure(25).
In that sense, an American publication has identified 
that 20% of women who received breast implants report 
pain even 5 years after the procedure(25), which corroborates 
the data found in which women who underwent surgery up 
to 10 years earlier reported the presence of pain more fre-
quently, as well as higher pain scores. This situation may be 
aggravated during the ‘milk let-down’ period, particularly in 
the cases of prepectoral implants due to the pressure of the 
implant on the mammary gland, which is already engorged, 
swollen and sore. 
We can point out the sample losses resulting from a 
follow-up study as a limitation in this study.
CONCLUSION
This study has led to the conclusion that the presence 
of pain and higher pain scores, the occurrence of lesion 
and the use of oral and nasal galactagogues were associ-
ated with implant placement, implant size and time elapsed 
since surgery.
Understanding the surgical characteristics and its 
association with variables related to breastfeeding helps 
to clarify the female population who wish to perform breast 
augmentation and later breastfeed, as well as those who are 
breastfeeding. In addition, it provides professional train-
ing for adequate management of the difficulties associated 
with breastfeeding and for the complexity of this process 
in the presence of breast implants, favoring integral and 
individual care to this population, as well as facilitating or 
providing the experience of breastfeeding, whether exclu-
sively or not.
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RESUMO
Objetivo: Analisar a associação entre as características cirúrgicas da mamoplastia de aumento, tempo decorrido da cirurgia, via de 
acesso, local de implantação e volume implantado e as variáveis relacionadas ao aleitamento, tipo, apojadura, ingurgitamento mamário, 
dor, lesão, produção láctea e uso de galactagogos. Método: Coorte prospectiva realizada entre 2015 e 2017, com 115 puérperas com 
mamoplastia de aumento durante a internação hospitalar (12 a 72 horas após o parto), atendimento domiciliar (5º ao 7º dia após o 
parto) e contato telefônico (entre o 30º e o 32º dia após o parto). Resultados: Na primeira avaliação, identificou-se o uso mais frequente 
de galactagogos orais (p=0,029) por puérperas com implante pré-peitoral, e de ocitocina spray por aquelas com prótese de até 270 ml 
(p=0,040). Na segunda avaliação, observou-se maior escore de dor naquelas com implante pré-peitoral (p=0,046). Em torno do 30º 
dia pós-parto, a presença de lesão mamilar (p=0,021), de dor (p=0,025) e seu maior escore (p=0,039) foram mais frequentes naquelas 
com mamoplastia realizada havia menos de 10 anos. Conclusão: A presença e o maior escore dor, a ocorrência de lesão e o uso dos 
galactagogos orais e nasal estiveram associados ao local de implantação, ao tamanho da prótese e ao tempo decorrido da cirurgia.
DESCRITORES
Aleitamento Materno; Mamoplastia; Implante Mamário; Enfermagem Obstétrica.
RESUMEN
Objetivo: En el presente estudio se analizó la asociación entre las características quirúrgicas de la mamoplastia de aumento, tiempo 
transcurrido de la cirugía, vía de acceso, lugar de implantación y volumen implantado y las variables relacionadas con la lactancia, tipo, 
apogeo, ingurgitación mamaria, dolor, lesión, producción láctea y uso de galactagogos. Método: Cohorte prospectiva realizada entre 
2015 y 2017, con 115 puérperas con mamoplastia de aumento durante la internación hospitalaria (12 a 72 horas después del parto), 
atención domiciliar (5º al 7º día después del parto) y contacto telefónico (entre el 30º y el 32º día después del parto). Resultados: 
En la primera evaluación, se identificó el uso más frecuente de galactagogos orales (p=0,029) por puérperas con implante pre-pectoral, 
y de ocitocina spray por aquellas con prótesis de hasta 270 ml (p=0,040). En la segunda evaluación, se observó mayor puntaje de dolor 
en aquellas con implante pre-pectoral (p=0,046). En torno al 30º día post-parto, la presencia de lesión mamilar (p=0,021), de dolor 
(p=0,025) y su mayor puntuación (p=0,039) fueron más frecuentes en aquellas con mamoplastia realizada hace menos de 10 años. 
Conclusión: La presencia y el mayor puntaje de dolor, la ocurrencia de lesión y el uso de los galactagogos orales y nasales estuvieron 
asociados al lugar de implantación, al tamaño de la prótesis y al tiempo transcurrido de la cirugía. 
DESCRIPTORES
Lactancia Materna; Mamoplastía; Implantación de Mama; Enfermería Obstétrica.
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